Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30367643 | 0.90 | MEN1 (0.34) | HTTMEN1KMT2ATSHR | |
| SCHEMBL17493142 | 0.90 | MEN1 (0.34) | HTTMEN1KMT2ATSHR | |
| SCHEMBL22939877 | 0.84 | HTT (0.31) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL15222418 | 0.81 | MEN1 (0.45) | HTTMEN1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL1543253 | 0.81 | HTT (0.35) | HTTMEN1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL17874179 | 0.79 | EPHX2 (0.36) | — | |
| SCHEMBL13382760 | 0.78 | LPAR3 (0.31) | — | |
| SCHEMBL13382751 | 0.77 | EPHX2 (0.31) | — | |
| SCHEMBL28827616 | 0.77 | HTT (0.37) | HTTMEN1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL9016318 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227936-A1 | EXTRACTING BASE METALS USING A WETTING AGENT AND A THIOCARBONYL FUNCTIONAL GROUP REAGENT | JETTI RESOURCES, LLC (US) | 2023-07-20 | — | — | US | disclosed |
| US-20210032567-A1 | ENVIRONMENTALLY COMPATIBLE DETERGENTS FOR INACTIVATION OF LIPID-ENVELOPED VIRUSES | BAXALTA INCORPORATED (US) | 2021-02-04 | — | — | US | disclosed |
| US-20160237112-A1 | PURIFICATION OF ORGANIC COMPOUNDS BY SURFACTANT MEDIATED PREPARATIVE HPLC | DAVULURI, RAMAMOHAN RAO (IN) | 2016-08-18 | — | — | US | disclosed |
| US-20160237112-A1 | PURIFICATION OF ORGANIC COMPOUNDS BY SURFACTANT MEDIATED PREPARATIVE HPLC | DAVULURI, RAMAMOHAN RAO (IN) | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032567-A1 | ENVIRONMENTALLY COMPATIBLE DETERGENTS FOR INACTIVATION OF LIPID-ENVELOPED VIRUSES | ABHD16A, LIPG, ABHD11 | HTT 2177/4885MEN1 3931/4885KMT2A 3608/4885 |
| US-20160237112-A1 | PURIFICATION OF ORGANIC COMPOUNDS BY SURFACTANT MEDIATED PREPARATIVE HPLC | CCR8, CXCL8, C9 | HTT 3518/4885MEN1 3986/4885KMT2A 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.